Envafolimab is under clinical development by Alphamab Oncology and currently in Phase I for Gastrointestinal Tract Cancer.

Biora Therapeutics, a reputable biotech firm listed on the NASDAQ under the ticker BIOR, recently made waves in the financial world by voluntarily filing a petition on December 27, 2024, under Chapter ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

I lost my sense of taste and smell due to Covid three years ago - can I do anything to help regain them? I am a 71-year-old ...

Discover the 9 crucial nutrients that play a vital role in maintaining your gut health, enhancing digestion, and boosting ...

Court filings and other information regarding Biora's court-supervised process is available at cases.ra.kroll.com/biora. The Company has set up an information line to answer questions about this ...

Eating a lot of highly processed foods is now associated with a “significant acceleration” of biological aging — a measure of ...

A new class of over-the-counter probiotic supplements claim to prevent hangovers by reducing gut acetaldehyde. Some ...

Future Prospects: The future of the Vietnam enteral feeding devices market is promising. As the aging population and the prevalence of chronic illnesses continue to increase, the demand for these ...